Recalls / Active ingredient / Magnesium Sulfate Heptahydrate
Magnesium Sulfate Heptahydrate
5 FDA drug recalls involving the active ingredient “Magnesium Sulfate Heptahydrate” — 2 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2018-10-03 | Class II | Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g Total, 500 mL Single-Dose Containe | Pfizer Inc. |
| 2016-01-05 | Class I | Magnesium Sulfate in Water for Injection, (0.325 mEq Mg++/mL) 40 mg/mL, 2 g Total, 50 mL Single-Dose Container | Hospira Inc. |
| 2015-04-28 | Class II | KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfit | Fresenius Kabi USA, LLC |
| 2015-03-06 | Class I | MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP, 10 mg/mL; 100 mL bag, Rx only, Hospira, Inc., Lake Forest, IL | Hospira Inc. |
| 2012-04-05 | Class III | Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, R | Hospira, Inc. |